Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rheumatoid Arthritis in Remission”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00989235
What this trial is testing

Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 108
Large-scale testing (Phase 3)Study completedNCT01007435
What this trial is testing

Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,162
Post-approval studies (Phase 4)Study completedNCT01881308
What this trial is testing

Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Diakonhjemmet Hospital 320
Not applicableStudy completedNCT01768923
What this trial is testing

Early RA Vascular Randomised Controlled Study

Who this might be right for
Early Rheumatoid Arthritis
Chinese University of Hong Kong 120
Not applicableStudy completedNCT03736044
What this trial is testing

Reconstitution of CD4+CD25highCD127low/-Tcell

Who this might be right for
Rheumatoid Arthritis
University Hospital of Ferrara 48
Post-approval studies (Phase 4)Study completedNCT01120366
What this trial is testing

Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation

Who this might be right for
Rheumatoid Arthritis
SURPRISE Study Group 233
Not applicableNot Yet RecruitingNCT06783322
What this trial is testing

Long-term Outcomes of Patients with Rheumatoid Arthritis in Remission

Who this might be right for
Rheumatoid Arthritis (RA)
Diakonhjemmet Hospital 259
Not applicableUnknownNCT04324892
What this trial is testing

Effects of Achieving SDAI Remission on Joint Space Outcomes Progression in Early Rheumatoid Arthritis: an HR-pQCT Study

Who this might be right for
Rheumatoid Arthritis
Chinese University of Hong Kong 110
Not applicableStudy completedNCT04343378
What this trial is testing

Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
University Hospital, Rouen 40
Post-approval studies (Phase 4)Study completedNCT00780793
What this trial is testing

Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study

Who this might be right for
Rheumatoid Arthritis
Assistance Publique - Hôpitaux de Paris 250
Post-approval studies (Phase 4)UnknownNCT04927000
What this trial is testing

The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Second Affiliated Hospital, Zhejiang University, School of Medicine 170
Large-scale testing (Phase 3)Ended earlyNCT00521924
What this trial is testing

Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)

Who this might be right for
Rheumatoid Arthritis
Merck Sharp & Dohme LLC 8
Post-approval studies (Phase 4)Ended earlyNCT05116228
What this trial is testing

Non-inferiority of Reduced-dose Rituximab in Rheumatoid Arthritis in Low Disease Activity and Remission

Who this might be right for
Rheumatoid ArthritisRemission
Medical University of Vienna 21
Large-scale testing (Phase 3)Study completedNCT02504268
What this trial is testing

Effects of Abatacept in Patients With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 994
Post-approval studies (Phase 4)UnknownNCT00716248
What this trial is testing

Bucillamine Study of Holding Remission After Infliximab Dose-off

Who this might be right for
Rheumatoid Arthritis
Saitama Medical University 40
Not applicableUnknownNCT02320630
What this trial is testing

Combination Therapy Prevents the Relapse of RA

Who this might be right for
Recurrence (Disease Attribute)
Peking University First Hospital 240
Large-scale testing (Phase 3)Study completedNCT01610791
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 121
Post-approval studies (Phase 4)Study completedNCT01557374
What this trial is testing

TOward the Lowest Effective DOse of Abatacept or Tocilizumab

Who this might be right for
Rheumatoid Arthritis
Assistance Publique - Hôpitaux de Paris 232
Post-approval studies (Phase 4)Study completedNCT01303874
What this trial is testing

Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)

Who this might be right for
Rheumatoid ArthritisInflammatory Arthritis
University of Leeds 112
Not applicableUnknownNCT01050010
What this trial is testing

The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study

Who this might be right for
Rheumatoid Arthritis
Centre Hospitalier Universitaire de Nice 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation